Literature DB >> 1888237

A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.

M H Prins1, J Hirsh.   

Abstract

We critically evaluated the evidence for an association between venous thromboembolism and impaired fibrinolytic activity, as determined by global tests of fibrinolytic activity or specific tests for tissue plasminogen activator and plasminogen activator inhibitor. A computer-assisted and manual search was performed to retrieve all articles that reported on fibrinolytic activity and venous thromboembolism. The strength of the evidence for an association was assessed by analysis of the design of individual studies with special attention directed to choice of controls and methods of diagnosis of venous thromboembolism. It is concluded that for patients with symptomatic thrombosis the published evidence does not prove an association between impaired fibrinolytic activity and increased risk of thrombosis. In contrast, for postoperative thrombosis there is good evidence for an association between impaired fibrinolytic activity measured either preoperatively or postoperatively and increased risk of postoperative thrombosis. Whether this association is causal or coincidental is unclear, since randomized clinical trials that used interventions to enhance fibrinolytic activity produced inconsistent results.

Entities:  

Mesh:

Year:  1991        PMID: 1888237

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Evaluation of Hypercoagulable States.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

Review 3.  Thrombophilia: a genetic predisposition to thrombosis.

Authors:  R A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

4.  4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Authors:  Francesco Burzotta; Licia Iacoviello; Augusto Di Castelnuovo; Roberto Zamparelli; Andria D'Orazio; Concetta Amore; Rocco Schiavello; Maria Benedetta Donati; Attilio Maseri; GianFederico Possati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

5.  Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis.

Authors:  E Wilder-Smith; I Kothbauer-Margreiter; B Lämmle; M Sturzenegger; C Ozdoba; S P Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

Review 6.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

Review 7.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

8.  Deep cerebral venous thrombosis and hereditary tissue plasminogen activator (t-PA) deficiency.

Authors:  F Tezzon; G Ferrari; V Sbarbaro; A Beltramello; P L Arigliano; M Negri
Journal:  Ital J Neurol Sci       Date:  1994-12

9.  Thrombophilia - how far and how much to investigate?

Authors:  R K Pinjala; L R C Reddy; R P Nihar; G V A Praveen; M Sandeep
Journal:  Indian J Surg       Date:  2012-01-13       Impact factor: 0.656

10.  Association of markers of hemostasis with death in HIV-infected women.

Authors:  Elizabeth Kiefer; Donald R Hoover; Qiuhu Shi; Mark H Kuniholm; Michael Augenbraun; Mardge H Cohen; Elizabeth T Golub; Robert C Kaplan; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Russell P Tracy; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.